Target intelligence / Profile preview

Beta-lactamase, class A (serine beta-lactamase) and class C (AmpC beta-lactamase) (TEM, SHV, CTX-M, KPC, AmpC)

Target
TEM, SHV, CTX-M, KPC, AmpC
Molecular classification
Enzyme, Hydrolase (EC 3.5.2.6)
01

Overview

Class A and C beta-lactamases are bacterial enzymes responsible for resistance to a wide range of beta-lactam antibiotics by hydrolyzing the four-membered beta-lactam ring. Class A enzymes (serine beta-lactamases) are common in Gram-negative bacteria and include well-known types such as TEM, SHV, CTX-M, and KPC, with the ability to hydrolyze penicillins, cephalosporins, and sometimes carbapenems. Class C enzymes (AmpC beta-lactamases) preferentially inactivate cephalosporins and are less susceptible to inhibition by traditional beta-lactamase inhibitors. Both are major contributors to hospital- and community-acquired bacterial resistance, posing critical challenges in infectious disease management. Detection of their activity or genes is a key biomarker for guiding appropriate antibiotic therapy.

Other names
Serine beta-lactamaseTEM beta-lactamaseSHV beta-lactamaseCTX-M beta-lactamaseKPC beta-lactamaseAmpC beta-lactamasecephalosporinase
02

Mechanism of action

Enzymatic hydrolysis of the beta-lactam ring, rendering beta-lactam antibiotics inactive

03

Biological functions

Antibiotic resistanceBeta-lactam antibiotic hydrolysis
04

Disease associations

Infection (particularly drug-resistant bacterial infection)
05

Safety considerations

Limited treatment options for infections caused by beta-lactamase-producing bacteriaPotential for rapid spread of resistance genes via plasmidsTherapeutic failure with standard beta-lactam antibiotics
06

Interacting drugs

penicillins

7 more in the full profile.

07

Biomarkers

Detection of beta-lactamase genes (e.g., bla_TEM, bla_SHV, bla_CTX-M, bla_KPC, bla_AmpC)Phenotypic resistance to beta-lactam antibiotics

Beyond the preview

Go deeper on Beta-lactamase, class A (serine beta-lactamase) and class C (AmpC beta-lactamase) (TEM, SHV, CTX-M, KPC, AmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactamase, class A (serine beta-lactamase) and class C (AmpC beta-lactamase) (TEM, SHV, CTX-M, KPC, AmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call